HLA-G expression protects porcine endothelial cells against natural, killer cell-mediated xenogeneic cytotoxicity

Transplantation

Volumn 67, Issue 1, 1999, Pages 31-37

  Sasaki, Hitomi ^a   Xu, Xiao Chun ^a   Smith, Douglas M ^b   Howard, Todd ^a   Mohanakumar, T ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN;

ANIMAL CELL; ANTIGEN EXPRESSION; ARTICLE; CELL ACTIVATION; CELL MEDIATED CYTOTOXICITY; CELL PROTECTION; CYTOLYSIS; GENETIC TRANSFECTION; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; XENOTRANSPLANTATION;

EID: 0033556548     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199901150-00005     Document Type: Article

References (40)

1. Trinchieri G. Biology of natural killer cells. Adv Immunol 1989; 47: 187.
2. Bancroft GJ. The role of natural killer cells in innate resistance to infection. Curr Opin Immunol 1993; 5: 503.
3. Kärre K, Ljunggren HG, Piontek G, Kiessling R. Selective rejection of H-2 deficient lymphoma variants suggests alternative immune defense strategy. Nature 1986; 319: 675.
4. Ljunggren HG, Kärre K. In search of the "missing self": MHC molecules and NK cell recognition. Immunol Today 1990; 11: 237.
5. Lanier LL. The role of natural killer cell in transplantation. Curr Opin Immunol 1995; 7: 626.
6. Lanier LL. Natural killer cell receptors and MHC class I interactions. Curr Opin Immunol 1997; 9: 126.
7. Moretta A, Bottino C, Vitale M, et al. Receptors for HLA class I molecules in human natural killer cells. Annu Rev Immunol 1996; 14: 619.
8. Grumperz JE, Parham P. The enigma of the natural killer cell. Nature 1995; 378: 245.
9. Lanier LL, Phillips JH. Inhibitory MHC class I receptors on NK cells and T cells. Immunol Today 1996; 17:86.
10. Döhring C, Scheidegger D, Samaridis J, Cella M, Colonna M. The human killer inhibitory receptor specific for HLA-A1,2. J Immunol 1996; 156: 3098.
11. Lanier LL, Gumperz JE, Parham P, Melero I, Lopez-Botes M, Phillips JH. The NKB1 and HP-3E4 NK cell receptors are structurally distinct glycoproteins and independently recognize polymorphic HLA-B and HLA-C molecules. J Immunol 1995; 154: 3320.
12. Wagtmann N, Rajagopalan S, Winter CC, Peruzzi M, Long EO. Killer cell inhibitory receptors specific for HLA-C and HLA-B identified by direct binding and by functional transfer. Immunity 1995; 3: 801.
13. Colonna M, Samaridis J. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. Science 1995; 268: 405.
14. Pazmany L, Mandelboim O, Vales-Gomez M, Davis DM, Reyburn HT, Strominger JL. Protection from natural killer cell-mediated lysis by HLA-G expression on target cells. Science 1996; 274: 792.
15. Munz C, Holmes N, King A, Loke YW, Colonna M, Schild H, Rammensee HG. Human histocompatibility leukocyte antigen (HLA)-G molecules inhibit NKAT3 expressing natural killer cells. J Exp Med 1997; 185: 385.
16. Perez-Villar JJ, Melero I, Navarro F, et al. The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. J Immunol 1997; 158: 5736.
17. Soderstrom K, Corliss B, Lanier LL, Phillips JH. CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. J Immunol 1997; 159: 1072.
18. Carretero M, Palmieri G, Llano M, et al. Specific engagement of the CD94/NKG2-A killer inhibitory receptor by the HLA-E class Ib molecule induces SHP-1 phosphatase recruitment to tyrosine-phosphorylated NKG2-A: evidence for receptor function in heterologous transfectants. Eur J Immunol 1998; 28: 1280.
19. Lee N, Llano M, Carretero M, et al. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc Natl Acad Sci USA 1998; 95: 5199.
20. Borrego F, Ulbrecht M, Weiss EH, Coligan JE, Brooks AG. Recognition of human histocompatibility leukocyte antigen (HLA)-E complexed with HLA class I signal sequence-derived peptides by CD94/NKG2 confers protection from natural killer cell-mediated lysis. J Exp Med 1998; 187: 813.
21. Braud VM, Allan DS, O'Callaghan CA, et al. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 1998; 391: 795.
22. Kaufman CL, Gaines BA, Ildstad ST. Xenotransplantation. Annu Rev Immunol 1995; 13:339.
23. Bach FH, Winkler H, Ferran C, Hancock WW, Robson SC. Delayed xenograft rejection. Immunol Today 1996; 17: 379.
24. Goodman DJ, Von Albertini M, Willson A, Millan MT, Bach FH. Direct activation of porcine endothelial cells by human natural killer cells. Transplantation 1996; 61: 763.
25. Malyguine AM, Saadi S, Platt JL, Dawson JR. Human natural killer cells induce morphologic changes in porcine endothelial cell monolayers. Transplantation 1996; 61: 161.
26. Blakely ML, Van der Welf WJ, Berndt MC, Dalmasso AP, Bach FH, Hancock WW. Activation of intragraft endothelial and mononuclear cells during discordant xenograft rejection. Transplantation 1994; 58: 1059.
27. Seebach, JD, Comrack C, Germana S, LeGuern C, Sachs DH, DerSimonian H. HLA-CwS expression on porcine endothelial cells protects against xenogeneic cytotoxicity mediated by a subset of human NK cells. J Immunol 1997; 159: 3655.
28. McMaster MT, Librach CL, Zhou Y, Lim KH, Janatpour MJ, DeMars R, Kovats S, Damsky C, Fisher SJ. Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. J Immunol 1995; 154: 3771.
29. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G expressed in human trophoblasts. Science 1990; 248: 220.
30. Reddel RR, Ke Y, Gerwin BI, et al. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phophate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res 1988; 48: 1904.
31. + cytolytic T cell clones. Transplantation 1997; 64: 340.
32. Shimizu Y, Geraghty DE, Koller BH, Orr HT, DeMars R. Transfer and expression of three cloned human non-HLA-A,B,C class I major histocompatibility complex genes in mutant lymphoblastoid cells. Proc Natl Acad Sci USA 1988; 85: 227.
33. Sullivan JA, Oettinger HF, Sachs DH, Edge AS. Analysis of polymorphism in porcine MHC class I genes. J Immunol 1997; 159: 2318.
34. Smith DM, Asbury J, Swearingen W, Hildebrand W. The structure of swine class I major histocompatibility antigens (SLA) [Abstract]. ASTP Meeting Abstr 1996; 142.
35. Ryan JC, Niemi EC, Nakamura MC, Seaman WE. NKR-P1A is a target-specific receptor that activates natural killer cell cytotoxicity. J Exp Med 1995; 181: 1911.
36. Germain RN. MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 1994; 76: 287.
37. Neefjes JJ, Momburg F, Hammerling GJ. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. Science 1993; 261: 769.
38. Milland J, Loveland BE, McKenzie IF. Isolation of a clone for pig β-2-microglobulin cDNA. Immunogenetics 1993; 38: 464.
39. Diehl M, Münz C, Keilholz W, et al. Nonclassical HLA-G molecules are classical peptide presenters. Curr Biol 1996; 6: 305.
40. Lee N, Malacko AR, Ishitani A, et al. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 1995; 3: 591.